SCHEMBL2001372

SCHEMBL2001372

c1nc(-c2c[nH]nn2)n[nH]1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3728792 0.81
SCHEMBL6610695 0.79
SCHEMBL87533 0.72
SCHEMBL9698096 0.71 KDM4E (0.38)
Hydrochloric Acid SCHEMBL18670804 0.71 KDM4E (0.34)
SCHEMBL1007639 0.71
SCHEMBL3532307 0.68
SCHEMBL381112 0.67 ALDH1A1 (0.46)
SCHEMBL22576658 0.67 KMO (0.35)
SCHEMBL10664039 0.67

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 61 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-118076128-A Light emitting device, manufacturing method thereof and display panel 北京维信诺科技有限公司 2024-05-24 CN claimed
CN-116715684-A Monovalent currency metal complex and preparation and application thereof 武汉大学 2023-09-08 CN claimed
US-8674113-B2 Compounds BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2014-03-18 US claimed
EP-2024385-A1 BETULIN DERIVED COMPOUNDS USEFUL AS ANTIBACTERIAL AGENTS Valtion Teknillinen Tutkimuskeskus (FI) 2009-02-18 EP claimed
WO-2007141389-A1 BETULIN DERIVED COMPOUNDS USEFUL AS ANTIBACTERIAL AGENTS VALTION TEKNILLINEN TUTKIMUSKESKUS (FI) 2007-12-13 WO claimed
US-20050119317-A1 Isoxazoline derivatives useful as antimicrobials ASTRAZENECA AB (SE) 2005-06-02 US claimed
US-20240239813-A1 KRAS INHIBITORS AND PHARMACEUTICAL USES THEREOF Risen (Suzhou) Pharma Tech Co., Ltd. (CN) 2024-07-18 US disclosed
CN-109943349-B Liquid-crystalline medium with homeotropic alignment 默克专利股份有限公司 2024-07-05 CN disclosed
WO-2024119277-A1 KRAS INHIBITORS AND PHARMACEUTICAL USES THEREOF Risen (Suzhou) Pharma Tech Co., Ltd. (CN) 2024-06-13 WO disclosed
WO-2024119278-A1 BIFUNCTIONAL COMPOUNDS AND PHARMACEUTICAL USES THEREOF Risen (Suzhou) Pharma Tech Co., Ltd. (CN) 2024-06-13 WO disclosed
US-20240059726-A1 GLYCOSYLATED HISTONE DEACETYLASE INHIBITORS AND METHODS OF MAKING AND USING THE SAME GEORGIA TECH RESEARCH CORPORATION 2024-02-22 US disclosed
CN-117222726-A Use of ketoacids for stabilizing lignin in lignocellulosic biomass extraction processes 理革公司 2023-12-12 CN disclosed
CN-115572284-A Crosslinkable host material 三星显示有限公司 2023-01-06 CN disclosed
US-20040058965-A1 Alkanoic acid derivatives process for their production and use thereof TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2004-03-25 US disclosed
EP-0825211-B1 Process for the preparation of allophanates containing aliphatic and/or cycloaliphatic and/or araliphatic isocyanate groups BAYER AG (DE) 2004-02-25 EP disclosed
US-20030158238-A1 Triazole-derived kinase inhibitors and uses thereof VERTEX PHARMACEUTICALS INCORPORATED 2003-08-21 US disclosed
US-20030064992-A1 N-aryl (thio) anthranilic acid amide derivatives, their preparation and their use as VEGF receptor tyrosine kinase inhibitors ALTMANN KARL-HEINZ (CH) 2003-04-03 US disclosed
US-6271243-B1 REDUCING SIDE EFFECTS OF DRUGS ADMINISTERED TO A DIABETIC PATIENT VIA ADMINISTERING PIOGLITAZONE DERIVATIVES/SALTS INSULIN SENSITIVITY ENHANCER DEPRESSES DIABETIC HYPERGLYCEMIA TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) 2001-08-07 US disclosed
US-5917083-A REACTING AN ISOCYANATE GROUP CONTAINING OXADIAZINETRIONE COMPOUND WITH AN PRIMARY ALCOHOL BAYER AKTIENGESELLSCHAFT (DE) 1999-06-29 US disclosed
EP-0302389-A2 Alpha-unsaturated amines, their production and use Takeda Chemical Industries, Ltd. (JP) 1989-02-08 EP disclosed